UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the Month of ~~December~~April ~~2015~~2016

Commission File No.: 001-35273

VIEWTRAN GROUP, INC.

Room 1501, Tower C, Skyworth Building,

High-Tech Industrial Park,

Nanshan, Shenzhen 518057, PRC

(Address of Principal Executive Offices.)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ~~_____~~____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _____

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨ No x

If “Yes” marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On ~~December~~April 1121, ~~2015~~2016, the Board of Directors (the “Board”) of Viewtran Group, Inc. (the “Company”) received a letter of resignation ~~from~~ from Dr. ~~George~~Xianhang ~~Mao,~~Wang ~~effective~~from ~~immediately.~~his Onpositions ~~December~~as ~~14, 2015,~~ the ~~Board~~Company’s ~~received~~Chief aExecutive ~~letter~~Officer ofand ~~resignation~~a ~~from Dr. Nathan Zhang~~director, effective immediately. ~~Each of~~ Dr. Wang ~~Mao and Dr. Zhang~~ indicated that his resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, polices or practices.

On the same date, the Board, which now consists solely of Jing Xu, appointed Mr. Xu the Chief Executive Officer of the Company.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

VIEWTRAN GROUP, INC. ~~By: /s/Xianhang Wang Name: Xianhang Wang Title: Chief Executive Officer~~

~~Dated~~By: ~~December 15, 2015~~/s/ Jing Xu

Name: Jing Xu

Title: Chief Executive Officer

Dated: April 27, 2016

Filing Compare · Viewtran Group, Inc.